Mesa Laboratories, Inc. (MLAB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 30, 2024, discloses the results of the annual meeting of shareholders held by Mesa Laboratories, Inc. The company is incorporated in Colorado and its common stock trades on The Nasdaq Stock Market LLC under the symbol MLAB.
Key Financial Metrics
This filing is a corporate governance report regarding shareholder voting results. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. No financial metrics are reported in this document.
Material Changes
There are no material financial changes reported in this filing. The document solely reports the certified outcomes of three shareholder proposals voted upon at the Annual Meeting.
Shareholder Voting Results and Governance
Out of 5,409,163 shares entitled to vote, 5,096,365 shares were represented at the meeting. The certified results were as follows:
- Proposal 1 (Election of Directors): All seven nominees were elected to one-year terms.
- Mark Capone: Received the highest support with 4,832,466 "For" votes and only 8,420 "Withheld" votes.
- Shiraz S. Ladiwala: Received 4,818,063 "For" votes.
- R. Tony Tripeny: Received 4,812,667 "For" votes.
- John J. Sullivan: Received 4,759,234 "For" votes.
- Gary M. Owens: Received 4,732,565 "For" votes.
- Shannon M. Hall: Received 4,727,530 "For" votes.
- Jennifer S. Alltoft: Received 4,667,909 "For" votes (highest "Withheld" count at 172,977).
- Proposal 2 (Ratification of Auditor): Shareholders approved the selection of RSM US LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2025.
- For: 4,992,593
- Against: 103,362
- Abstain: 410
- Proposal 3 (Executive Compensation): The compensation of named executive officers was approved on a non-binding advisory basis.
- For: 4,581,083
- Against: 226,773
- Abstain: 33,030
Investor Verification Checklist
- Verify the full composition of the newly elected Board of Directors and their biographies in the company's Proxy Statement.
- Review the Proxy Statement for details on the specific compensation packages approved under Proposal 3.
- Confirm the engagement letter terms with RSM US LLP for the fiscal year ending March 31, 2025.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.